Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1974-11-25
1976-07-06
Drezin, Norman A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424269, 424270, 424273, A61K 3144
Patent
active
039682161
ABSTRACT:
A method of inhibiting histamine activity in particular inhibiting H-2 histamine receptors, by administering heterocyclicalkylguanidines.
REFERENCES:
patent: 2928829 (1960-03-01), Mull
patent: 3036083 (1962-05-01), Mull
patent: 3278542 (1966-10-01), Wollweber et al.
patent: 3354174 (1967-11-01), Bell
Derwent Pharmdoc. 586095-B Abstracting Belgian Patent No. 763744, published 3-9-71.
Black James Whyte
Durant Graham John
Emmett John Colin
Ganellin Charon Robin
Drezin Norman A.
Edgerton William H.
Foggio Richard D.
Keps Joan S.
Smith Kline & French Laboratories Limited
LandOfFree
Method of inhibiting histamine activity with guanidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting histamine activity with guanidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting histamine activity with guanidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1533813